Oxycodon-Hcl Retard Accord (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodon-Hcl Retard Accord, is an opioid analgesic presented as a prolonged‑release oral tablet for oral use. It is employed to manage moderate to severe pain in adult patients when continuous, around‑the‑clock treatment is required.

GNH USA supplies Oxycodon-Hcl Retard Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodon-Hcl Retard Accord is an opioid analgesic that acts on the central nervous system to relieve pain. - Chronic cancer‑related pain: provides long‑lasting relief for patients with persistent tumor‑associated pain. - Post‑operative pain: maintains steady analgesia after major surgical procedures. - Severe musculoskeletal pain: reduces pain intensity in conditions such as advanced osteoarthritis or rheumatoid arthritis when other treatments are insufficient.

Adverse reactions vary with dose and patient factors.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: mild to moderate upset stomach. - Drowsiness: increased sleepiness or sedation. - Dry mouth: decreased salivary flow. - Dizziness: sensation of light‑headedness. - Itching: mild pruritus, often localized.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Opioid dependence or addiction: potential for misuse and physical dependence. - Seizures: rare occurrence of convulsive episodes. - Anaphylaxis: acute allergic reaction with rash, swelling, and airway compromise.

When prescribing Oxycodon-Hcl Retard Accord, clinicians should evaluate patient history and monitor for adverse events. - Assess pain severity: confirm that opioid therapy is appropriate for the level of pain. - Review medical history: identify respiratory disorders, head injury, or gastrointestinal obstruction. - Monitor for dependence: watch for signs of tolerance, misuse, or addiction. - Avoid abrupt discontinuation: taper dose gradually to prevent withdrawal symptoms. - Concomitant CNS depressants: use with caution when combined with benzodiazepines or alcohol. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodon-Hcl Retard Accord can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and profound sedation. - Benzodiazepines: heightened risk of profound CNS depression and respiratory compromise. - Central nervous system depressants: increased likelihood of severe sedation and hypotension.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise oxy‑acetyl plasma concentrations. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): can alter metabolic clearance. - Anticholinergic agents: may exacerbate constipation and urinary retention.